ERYTECH PHARMA (ERYP.PA) Stock Price, Forecast & Analysis

EPA:ERYP • FR0011471135

0.801 EUR
+0 (+0.25%)
Last: Jun 28, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership

ERYP.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap24.84M
Revenue(TTM)7.66M
Net Income(TTM)-17.28M
Shares31.02M
Float32.52M
52 Week High1.48
52 Week Low0.28
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.56
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2013-05-07
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
ERYP.PA short term performance overview.The bars show the price performance of ERYP.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80 100

ERYP.PA long term performance overview.The bars show the price performance of ERYP.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of ERYP.PA is 0.801 EUR. In the past month the price decreased by -8.56%. In the past year, price decreased by -28.23%.

ERYTECH PHARMA / ERYP Daily stock chart

ERYP.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
ERYP.PA Full Technical Analysis Report

ERYP.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ERYP.PA. ERYP.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ERYP.PA Full Fundamental Analysis Report

ERYP.PA Financial Highlights

Over the last trailing twelve months ERYP.PA reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 99.68% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%102.44%
Sales Q2Q%198.12%
EPS 1Y (TTM)99.68%
Revenue 1Y (TTM)59.04%
ERYP.PA financials

ERYP.PA Forecast & Estimates

9 analysts have analysed ERYP.PA and the average price target is 3.67 EUR. This implies a price increase of 358.43% is expected in the next year compared to the current price of 0.801.

For the next year, analysts expect an EPS growth of 22.35% and a revenue growth 16.44% for ERYP.PA


Analysts
Analysts42.22
Price Target3.67 (358.18%)
EPS Next Y22.35%
Revenue Next Year16.44%
ERYP.PA Analyst EstimatesERYP.PA Analyst Ratings

ERYP.PA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
ERYP.PA Ownership

ERYP.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1AE ARGENX SE27.8943.962B
ARGX ARGENX SE27.943.888B
22UA BIONTECH SE-ADR N/A22.579B
ABVX ABIVAX SA N/A8.651B
2X1 ABIVAX SA N/A8.619B
GXE GALAPAGOS NV N/A1.957B
GLPG GALAPAGOS NV N/A1.948B
IVA INVENTIVA SA N/A1.18B
6IV INVENTIVA SA N/A1.174B
NANO NANOBIOTIX N/A1.048B

Related stock screener links

View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges

About ERYP.PA

Company Profile

ERYP logo image ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. The firm offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The firm's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.

Company Info

ERYTECH PHARMA

60 avenue Rockefeller, Batiment Adenine

Lyon AUVERGNE-RHONE-ALPES FR

Employees: 49

ERYP Company Website

Phone: 33478744438.0

ERYTECH PHARMA / ERYP.PA FAQ

What does ERYTECH PHARMA do?

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. The firm offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The firm's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.


What is the current price of ERYP stock?

The current stock price of ERYP.PA is 0.801 EUR. The price increased by 0.25% in the last trading session.


What is the dividend status of ERYTECH PHARMA?

ERYP.PA does not pay a dividend.


What is the ChartMill technical and fundamental rating of ERYP stock?

ERYP.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the GICS sector and industry of ERYP stock?

ERYTECH PHARMA (ERYP.PA) operates in the Health Care sector and the Biotechnology industry.


Can you provide the ownership details for ERYP stock?

You can find the ownership structure of ERYTECH PHARMA (ERYP.PA) on the Ownership tab.